Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the fourth quarter and year-end 2024 and ...
GlobalData on MSN9h
Eli Lilly pays $10m upfront for Organovo’s FXR agonistEli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...
Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a ...
Zacks.com on MSN7h
Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDAIt was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and ...
Stylecaster on MSN3h
Michelle Trachtenberg Addressed Claims She Looked ‘Sick' Months Before Her DeathHollywood is mourning the loss of another young life, and with the news of Michelle Trachtenberg’s death, there have been a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback